(Q3)Feb 29, 2024 | (Q2)Nov 30, 2023 | (Q1)Aug 31, 2023 | (FY)May 31, 2023 | (Q4)May 31, 2023 | (Q3)Feb 28, 2023 | (Q2)Nov 30, 2022 | (Q1)Aug 31, 2022 | (FY)May 31, 2022 | (Q4)May 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -400.53%-104.5K | 32.71%-91.86K | 72.19%-86.8K | 10.10%-538.21K | 51.57%-124.35K | 145.71%34.77K | 5.08%-136.51K | -155.78%-312.12K | -2.65%-598.66K | -82.58%-256.75K |
Net income from continuing operations | -1.19%-96.11K | 18.02%-91.75K | 60.57%-87.18K | 17.77%-541.07K | 60.33%-113.06K | 3.18%-94.98K | 47.08%-111.92K | -248.94%-221.11K | -8.49%-657.96K | -73.10%-285.01K |
Asset impairment expenditure | ---- | ---- | ---- | --11.59K | ---- | ---- | ---- | ---- | --0 | ---- |
Remuneration paid in stock | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 4,179.00%120.24K | -92.31%216 |
Other non cashItems | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---650 | ---- | ---- |
Change In working capital | -106.47%-8.39K | 99.52%-117 | 100.42%380 | 85.67%-8.73K | -181.60%-22.88K | 488.93%129.75K | 53.02%-24.59K | -55.14%-91.01K | -397.55%-60.94K | 32.22%28.04K |
-Change in receivables | -106.63%-6.51K | 69.14%-3.87K | 129.77%7.23K | 296.11%54.67K | 47.98%-6.66K | 1,358.39%98.17K | -91.83%-12.54K | -3,236.81%-24.29K | ---27.88K | ---12.81K |
-Change in prepaid assets | -19.19%4.39K | -19.20%4.39K | 97.10%-210 | 80.51%-2.53K | 43.29%-6.18K | --5.44K | --5.44K | -243.91%-7.23K | -123.72%-12.99K | -119.88%-10.89K |
-Change in payables and accrued expense | -124.00%-6.28K | 96.35%-639 | 88.83%-6.64K | -203.31%-60.87K | -119.41%-10.04K | -12.34%26.15K | 61.83%-17.49K | -6.55%-59.49K | 41.50%-20.07K | 310.07%51.74K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -400.53%-104.5K | 32.38%-91.86K | 72.25%-86.8K | 10.10%-538.21K | 51.40%-124.35K | 145.06%34.77K | 5.39%-135.86K | -156.31%-312.77K | -2.65%-598.66K | -81.95%-255.87K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 372.75%31.61K | -11.59K | -11.09K | |||||||
Net PPE purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---11.59K | ---11.09K |
Net other investing changes | ---- | ---- | ---- | --31.61K | ---- | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | ---- | ---- | ---- | 372.75%31.61K | ---- | ---- | ---- | ---- | ---11.59K | ---11.09K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 0 | 28.16%167.25K | 0 | |||||||
Net common stock issuance | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 28.16%167.25K | --0 |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 28.16%167.25K | --0 |
Net cash flow | ||||||||||
Beginning cash position | -47.46%261.94K | -44.23%353.8K | -53.48%440.6K | -31.87%947.2K | -56.07%533.34K | -61.41%498.57K | -55.80%634.43K | -31.87%947.2K | -24.57%1.39M | -13.29%1.21M |
Current changes in cash | -400.53%-104.5K | 32.38%-91.86K | 72.25%-86.8K | -14.36%-506.6K | 65.26%-92.74K | 144.77%34.77K | 5.39%-135.86K | -791.64%-312.77K | 2.15%-443K | -2,536.06%-266.95K |
End cash Position | -70.48%157.43K | -47.46%261.94K | -44.23%353.8K | -53.48%440.6K | -53.48%440.6K | -56.07%533.34K | -61.41%498.57K | -55.80%634.43K | -31.87%947.2K | -31.87%947.2K |
Free cash from | -400.53%-104.5K | 32.38%-91.86K | 72.25%-86.8K | 11.80%-538.21K | 53.42%-124.35K | 144.77%34.77K | 5.39%-135.86K | -156.31%-312.77K | -4.64%-610.25K | -89.83%-266.95K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data